Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. Among authors: sabbagh m. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Hippocampal sclerosis dementia with tauopathy.
Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D, Baker M, Sahara N, Yen SH, Hutton M, Caselli R, Adler C, Connor D, Sabbagh M. Beach TG, et al. Among authors: sabbagh m. Brain Pathol. 2003 Jul;13(3):263-78. doi: 10.1111/j.1750-3639.2003.tb00027.x. Brain Pathol. 2003. PMID: 12946017 Free PMC article.
A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT).
Sparks DL, Lopez J, Connor D, Sabbagh M, Seward J, Browne P; Alzheimer's Disease Cholesterol-Lowering Treatment Team. Sparks DL, et al. Among authors: sabbagh m. J Mol Neurosci. 2003;20(3):407-10. doi: 10.1385/JMN:20:3:407. J Mol Neurosci. 2003. PMID: 14501025 Clinical Trial.
The use of memantine in dementia with Lewy bodies.
Sabbagh MN, Hake AM, Ahmed S, Farlow MR. Sabbagh MN, et al. J Alzheimers Dis. 2005 Aug;7(4):285-9. doi: 10.3233/jad-2005-7403. J Alzheimers Dis. 2005. PMID: 16131729
917 results